Α-Methylmethcathinone
Pharmaceutical compound
From Wikipedia, the free encyclopedia
α-Methylmethcathinone (α-Me-MC), also known as βk-mephentermine or as RAD-081, is a norepinephrine–dopamine releasing agent (NDRA) of the amphetamine, cathinone, and phentermine families.[1][2][3] It is the α-methyl analogue of methcathinone and the β-keto analogue of mephentermine.[1][2][3] The drug's EC50 values for induction of monoamine release are 153 nM for norepinephrine, 590 nM for dopamine, and 12,860 nM for serotonin in rat brain synaptosomes.[1][2][3] α-Methylmethcathinone was first described in the scientific literature by 2019.[1][2][3]
Other namesα,N-Dimethylcathinone; β-Keto-N-methylphentermine; β-Keto-α,N-dimethylamphetamine; β-Keto-α,α,N-trimethylphenethylamine; α-Methylmethcathinone; α-Me-MC; βk-Mephentermine; RAD-081; RAD081
| Clinical data | |
|---|---|
| Other names | α,N-Dimethylcathinone; β-Keto-N-methylphentermine; β-Keto-α,N-dimethylamphetamine; β-Keto-α,α,N-trimethylphenethylamine; α-Methylmethcathinone; α-Me-MC; βk-Mephentermine; RAD-081; RAD081 |
| Drug class | Norepinephrine–dopamine releasing agent |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C11H15NO |
| Molar mass | 177.247 g·mol−1 |
| 3D model (JSmol) | |
| |
| |